Six essential digital capabilities to accelerate cell and gene therapy R&D
Cell and gene therapies have entered a new era of industrialization. In the race to address unmet medical needs with more targeted biopharmaceuticals, companies face a new set of challenges: data management and traceability, cross-functional collaboration, and decision management. Modern R&D teams are looking to enhance their digital foundation with capabilities that address these challenges.
This solution guide discusses:
Six essential digital capabilities that cell and gene therapies should be thinking about to accelerate their R&D, and a perspective on how Benchling’s R&D Cloud is delivering on these with a modern digital solution.